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Number of Surgically Removed Mediastinal Lymph-Nodes 
(SRMLNs) as prognostic factor for survival in resected early stage 
non-small-cell lung cancer (NSCLC): a retrospective analysis of a 
mono-institutional series
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Background: The impact on outcome provided by the extent of lym-
phoadenectomy in patients undergoing lobectomy or pneumonectomy 
for early stage (I-IIIA) NSCLC is still controversial. Several reports 
have documented a non signiﬁcant effect of such procedure on both 
disease-free and overall-survival (DFS/OS). Nevertheless, especially 
in trials of adjuvant chemotherapy, a very wide range of nodes number 
across all series is reported, strongly suggesting a clariﬁcation about the 
eventual supposed prognostic role of this intervention.
Methods: A retrospective series of resected NSCLC patients was 
retrieved from the ﬁles of the Regina Elena National Cancer Institute. 
Correlation between known prognostic factors (sex, type of surgery, 
histology, tumor size, node involvement, grading) plus the number of 
SRMLNs and clinical outcome (DFS and OS) was then retrospectively 
explored using both the Cox regression model (considering SRMLNs 
as quantitative variable; signiﬁcance cut-off<0.10) as well as classiﬁca-
tion and regression trees (CART) analysis.
Results: Data referring to 122 NSCLC patients who underwent surgery 
for stage I-IIIA NSCLC were collected. Multivariate analysis identiﬁed 
SRMLNs as signiﬁcant independent predictors of both DFS and OS, 
with an hazard ratio of 0.94 (95% CI 0.90, 0.97, p=0.003), and 0.94 
(95% CI 0.90, 0.99, p=0.035), respectively, together with nodal in-
volvement, and grading G3. The CART analysis identiﬁed 26 removed 
nodes as the cut-off for better outcome. When considering SRMLNs 
as categorical variable, patients with more than 26 removed nodes had 
a signiﬁcant better DFS and OS, with an hazard ratio of 3.90 (95% CI 
1.16, 13.09, p=0.027), and 4.01 (95% CI 0.93, 18.18, p=0.063), respec-
tively, at the multivariate analysis.
Conclusions: Data presented herein open the issue that prognosis of 
early stage of NSCLC can be inﬂuenced by the extent of mediastinal 
lymphoadenectomy. Further prospective analyses are needed to conﬁrm 
this ﬁnding.
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Background: More people now live longer and healthier lives, and 
consequently more patients in high ages with potentially operable lung 
tumours are seen. The aim of the present investigation was to evaluate 
survival after surgery in those patients.
Material: All patients aged 80 years or above who had surgery for 
lung cancer from 1991 to 2005 at the Karolinska University Hospital 
Sweden were retrospectively reviewed.
Results: There were 49 patients, 16 women and 33 men. The mean 
age was 81.6 years and the oldest patient was 87 years. Fifteen were 
current smokers, 24 ex-smokers, 9 had never smoked and data was 
missing in one. Their PS was 0-1. Preoperative diagnosis was available 
in 14 cases. The upper lobe was removed in 21 patients (right 11, left 
10), the lower lobe in 19 (right 10 and left 9), middle lobe in 2, both 
middle and upper lobe also in 2, and pulmectomy in 5 patients (2 right 
and 3 left). Two patients had to be reoperated acutely, both because of 
haemorrhage intrathoracically. There was no peroperative mortality. 
Of the patients who had a pulmectomy, two died within 3 months, both 
due to metastases. The other lived approximately 6, 12 and 25 months 
respectively. Of those 19 operated the ﬁrst 5 years, 4 are still alive. The 
longest survivor was operated with right upper lobectomy at age 81 in 
1993. Of 36 operated before February 2002, 17 patients survived more 
than 5 years. In all, 18 patients are still alive. 
Conclusion: Thoracic surgery in patients aged 80 years or more is 
feasible if they have a good PS and long-term survival can be expected 
in a signiﬁcant number. Peroperative morbidity and mortality are low. 
With better staging methods such as PET, results can probably be 
improved. An alternative to surgery is precision radiotherapy but com-
parative studies are missing.
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Objective: The aim of the current study is to collect and compile fac-
tors that could inﬂuence the survival of patients who have undergone 
surgical treatment for bronchial carcinoids. 
Background: Bronchial carcinoids account for 0.5-5% of all lung 
tumours according to different sources from literature. In Sweden there 
is an incidence of 0.7 / 100 000 corresponding to 60-70 new cases 
every year. Of these 90 % can be classiﬁed as typical carcinoids (TC). 
TC is a low malignant tumour with a ﬁve year survival rate of 87-100 
%. The atypical carcinoid (AC) shows a more aggressive behaviour 
with high mortality rate and a strong tendency to produce metastases. It 
has not come to a consensus whether pulmonary carcinoids should be 
operated with an anatomical resection or if parenchymal saving surgery 
is enough. It is also a matter of debate if a radical lymphadenectomy is 
indicated by patients with pulmonary carcinoids. 
Methods: Data were collected retrospectively from 1097 patients who 
underwent surgical treatment on the indication suspected or proven 
bronchial malignancy at Huddinge University Hospital Stockholm, 
Sweden, from the start of the departement 1992 to the fusion with 
Karolinska Hospital 2004. From this base we identiﬁed all bronchial 
carcinoids being operated. All tumours were then classiﬁed according 
to the 1999 WHO classiﬁcation. All patients were included in a routine 
follow up program, which included x-ray of the lungs and physical 
examination every 12 month. Cumulative survival was estimated by the 
Kaplan Meier method. Differences in survival were tested for sub-
groups using log rank test. 
Results: There were 39 patients with bronchial carcinoids, constitut-
ing 6 % of all operated and diagnosed lung tumours. Of these 20 were 
males and 19 females. Thirtyone of the 39 patients were classiﬁed 
